Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 37, pseudogene (RNU6-37P) is a genomic sequence resembling the U6 small nuclear RNA gene but contains mutations that prevent it from functioning as a small nuclear RNA[1][3]. Functional U6 snRNA is a core component of the major spliceosome and is essential for pre-mRNA splicing in eukaryotic cells, but RNU6-37P does not produce a functional RNA product and does not participate in cellular processes[2][3]. Pseudogenes like RNU6-37P are typically regarded as nonfunctional genetic elements with no direct biological or therapeutic relevance.\n\nIf you are seeking information on the active U6 small nuclear RNA, those are not considered drug targets per se, but they are essential for mRNA processing in the cell nucleus[2][3]. RNU6-37P, as a pseudogene, is not a suitable molecular target for therapeutics, research, or biomarker purposes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 37, pseudogene (RNU6-37P).